🔗 Share this article

Chancellor Rachel Reeves has revealed she is planning "specific measures to address cost of living pressures" in next month's Budget.

In comments to media outlets, she emphasized that lowering inflation is a joint duty of both the administration and the Bank of England.

The United Kingdom's inflation rate is projected to be the highest among the Group of Seven industrialized countries this year and the following year.

Possible Utility Bill Measures

Reports indicate the government could take action to lower utility costs, such as by cutting the current 5% level of value-added tax charged on energy supplies.

A further possibility is to lower some of the regulatory levies currently included in household expenses.

Budgetary Limitations and Analyst Predictions

The government will obtain the next report from the official forecaster, the Office for Budget Responsibility, on Monday, which will clarify how much space there is for these measures.

The view from the majority of analysts is that Reeves will have to declare higher taxes or spending cuts in order to adhere to her declared borrowing rules.

Previously on Thursday, analysis suggested there was a twenty-two billion pound deficit for the Treasury chief to fill, which is at the more modest range of forecasts.

"It is a collective task between the Bank of England and the administration to bear down further on some of the sources of price increases," Reeves told reporters in the US capital, at the yearly gatherings of the IMF and global financial institution.

Revenue Pledges and Global Concerns

While much of the focus has been on expected tax rises, the chancellor said the latest data from the fiscal watchdog had not altered her pledge to election pledges not to raise rates on income tax, sales tax or social security contributions.

She blamed an "unpredictable world" with increasing international and commercial issues for the Budget tax moves, probably to be directed on those "most able to pay."

International Economic Disputes

Referring to worries about the United Kingdom's trade ties with China she said: "The UK's security interests invariably are paramount."

Recent statement by Chinese authorities to strengthen trade restrictions on critical minerals and other materials that are essential for advanced tech manufacturing led American leader the US President to propose an additional 100% tariff on goods from China, increasing the possibility of an full-scale commercial conflict between the two largest economies.

The US Treasury Secretary labeled the Chinese decision "economic coercion" and "a international production power grab."

Inquired about accepting the American proposal to participate in its conflict with China, the Chancellor said she was "very concerned" by Chinese measures and encouraged the Chinese government "to avoid restrictions and limit trade."

She said the decision was "bad for the international commerce and causes further challenges."

"I believe there are fields where we need to address Chinese policies, but there are also valuable prospects to sell into China's economy, including financial services and other areas of the economy. We've got to achieve that balance correct."

The chancellor also confirmed she was collaborating with other major economies "on our own essential resources approach, so that we are reduced dependence."

Health Service Drug Pricing and Investment

Reeves also acknowledged that the cost the NHS pays for pharmaceuticals could rise as a consequence of current discussions with the US government and its drugs companies, in return for lower tariffs and capital.

Some of the world's largest drug companies have said in recent statements that they are either halting or abandoning operations in the UK, with several blaming the low prices they are obtaining.

Last month, the government science advisor said the price the NHS pays for medicines would have to go up to prevent companies and drug research funding leaving the United Kingdom.

Reeves told media: "We have seen because of the pricing regime, that medical research, recent pharmaceuticals have not been provided in the United Kingdom in the manner that they are in other EU nations."

"The objective is to guarantee that patients getting treatment from the National Health Service are can receive the finest essential drugs in the world. And so we are examining all of that, and... seeking to secure increased investment into Britain."